-
Featured Press Release
Aspira Women’s Health Reports First Quarter 2022 Financial Results
Learn More -
Press Release
Aspira Women’s Health to Announce First Quarter 2022 Financial Results and Host Conference Call on Wednesday, May 11
Learn More -
Press Release
Aspira Women’s Health Reports Fourth Quarter and Full Year 2021 Financial Results
Learn More
Recent News
Choose a Category:
-
Aspira Women’s Health Reports First Quarter 2022 Financial Results
Press Release
Product Revenue Increased 30% to $1.8 million; OVA1plus Volume Grew 28% to 4,819 Units New Ordering Physicians in the First Quarter Grew 47% to 603 Year Over Year Board and Leadership appointments announced Conference Call and Webcast scheduled for today, May 11th at 8:30 a.m. ET AUSTIN, Texas — May 11, 2022 — Aspira Women’s Health…
-
Aspira Women’s Health to Announce First Quarter 2022 Financial Results and Host Conference Call on Wednesday, May 11
Press Release
AUSTIN, Texas, April 29, 2022 (GLOBE NEWSWIRE) — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that the company will report its financial results for the first quarter ended March 31, 2022 before the market open on Wednesday, May 11, 2022. Management will also host a conference call with investors…
-
Aspira Women’s Health Reports Fourth Quarter and Full Year 2021 Financial Results
Press Release
Total Revenue Increased 46% to $6.8 million; OVA1 Volume Grew 28% to 17,359 Units Exercise of option in the Harvard Dana-Farber Cancer Institute Collaboration Leadership and Board appointments implemented in First Quarter of 2022 Conference Call and Webcast scheduled for today, March 23rd at 8:30 a.m. ET AUSTIN, Texas —March 23, 2022 — Aspira Women’s…
-
Aspira Women’s Health to Announce Year End 2021 Financial Results and Host Conference Call on Wednesday, March 23rd
Press Release
AUSTIN, Texas —March 15, 2022 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that the company will report its financial results for the year ended December 31, 2021 before the market open on Wednesday, March 23, 2022. Management will also host a conference call with investors to discuss financial…
-
Aspira Women’s Health Announces Appointment of Celeste Fralick, Ph.D., to its Board of Directors
Press Release
AUSTIN, Texas —Feb. 28, 2022 — Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced the appointment of Celeste Fralick, Ph.D., to its Board of Directors, effective February 23, 2022. Dr. Fralick is an accomplished executive with over four decades of data strategy experience. She brings to the Board a broad…